TY - JOUR
T1 - The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function
AU - Reiterer, Veronika
AU - Figueras-Puig, Cristina
AU - Le Guerroue, Francois
AU - Confalonieri, Stefano
AU - Vecchi, Manuela
AU - Jalapothu, Dasaradha
AU - Kanse, Sandip M.
AU - Deshaies, Raymond J.
AU - Di Fiore, Pier Paolo
AU - Behrends, Christian
AU - Farhan, Hesso
PY - 2016
Y1 - 2016
N2 - The F-box protein FBXW7 is the substrate-recruiting subunit of an SCF ubiquitin ligase and a major tumor-suppressor protein that is altered in several human malignancies. Loss of function of FBXW7 results in the stabilization of numerous proteins that orchestrate cell proliferation and survival. Little is known about proteins that directly regulate the function of this protein. In the current work, we have mapped the interactome of the enigmatic pseudophosphatase STYX. We reasoned that a catalytically inactive phosphatase might have adopted novel mechanisms of action. The STYX interactome contained several F-box proteins, including FBXW7. We show that STYX binds to the F-box domain of FBXW7 and disables its recruitment into the SCF complex. Therefore, STYX acts as a direct inhibitor of FBXW7, affecting the cellular levels of its substrates. Furthermore, we find that levels of STYX and FBXW7 are anti-correlated in breast cancer patients, which affects disease prognosis. We propose the STYX-FBXW7 interaction as a promising drug target for future investigations.
AB - The F-box protein FBXW7 is the substrate-recruiting subunit of an SCF ubiquitin ligase and a major tumor-suppressor protein that is altered in several human malignancies. Loss of function of FBXW7 results in the stabilization of numerous proteins that orchestrate cell proliferation and survival. Little is known about proteins that directly regulate the function of this protein. In the current work, we have mapped the interactome of the enigmatic pseudophosphatase STYX. We reasoned that a catalytically inactive phosphatase might have adopted novel mechanisms of action. The STYX interactome contained several F-box proteins, including FBXW7. We show that STYX binds to the F-box domain of FBXW7 and disables its recruitment into the SCF complex. Therefore, STYX acts as a direct inhibitor of FBXW7, affecting the cellular levels of its substrates. Furthermore, we find that levels of STYX and FBXW7 are anti-correlated in breast cancer patients, which affects disease prognosis. We propose the STYX-FBXW7 interaction as a promising drug target for future investigations.
KW - Breast cancer
KW - Cullin-RING ubiquitin ligase
KW - F-box protein
KW - Mass spectrometry
KW - Pseudophosphatase
UR - http://www.scopus.com/inward/record.url?scp=85007071908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007071908&partnerID=8YFLogxK
U2 - 10.15252/embj.201694795
DO - 10.15252/embj.201694795
M3 - Article
AN - SCOPUS:85007071908
SN - 0261-4189
JO - EMBO Journal
JF - EMBO Journal
ER -